The American Medical Association (AMA) has called for a regulatory crackdown on chatbots and wellness AI, emphasizing the need for oversight in these emerging technologies.
This appeal comes amid growing concerns regarding the implications of AI tools in clinical settings, particularly those developed by companies like OpenAI.
As telehealth services expand, the AMA's stance reflects a cautious approach to ensure patient safety and the integrity of healthcare delivery.